Intrexon | Ativo Circulante



Current Assets Alterar Data
Alaunos Therapeutics USD 2.76M 795K 2024-12
Amgen USD 26.93B 2.1B 2025-03
Arrowhead Research USD 1.14B 564.68M 2025-03
AstraZeneca USD 26.14B 312M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Incyte USD 3.23B 7.24M 2025-03
Ligand Pharmaceuticals USD 309.32M 22.24M 2025-03
MacroGenics USD 217.49M 4.71M 2024-12
MannKind USD 273.74M 5.43M 2025-03
Merck USD 35.5B 3.28B 2025-03
Novartis USD 29.7B 1.56B 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
Thermo Fisher Scientific USD 23.38B 1.24B 2025-03
Veracyte USD 383.15M 10.88M 2025-03
Xencor USD 521.27M 56.33M 2025-03



Intrexon Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2025.